Zinc Thymulin

Zinc Thymulin

Zinc Thymulin (ZT) is used to regenerate hair lost as a result of androgenic alopecia, commonly called male pattern baldness -which affects women too !

Most hair loss involves inactivation of hair follicles, that is, hair follicles cease to grow enough hair to keep up with the natural amount of hair loss that occurs every day.hair.

Zinc and thymulin are two natural compounds involved in hair follicle growth and have been studied and found to promote hair growth. Combined into a spray solution, Zinc/Thymulin can be applied to the scalp and treat hair loss, bald patches and initiate the angen hair growth phase (the active growth phase of hair follicles during which the root of the hair is dividing rapidly).

Testing has shown to be safe and effective, with proven clinical results published in the peer reviewed medical journal Hair Therapy and Transplantation.

We know what zinc is, what is thymulin?

Thymulin is a peptide hormone derived from the thymus gland. The activity of the hormone is reliant on the mineral Zinc, which is why it is referred to as Zinc Thymulin.

Benefits of ZT:

  • Can prevent hair loss
  • Can improve hair growth
  • Can improve quantity of hair
  • Can improve endogenous hair pigmentation
  • Both women and men can be treated
  • Treatment may be combined with known other hair restoration methods

Lack of side Effects:

In the study “An Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia“ Zinc Thymulin demonstrated no adverse systemic effects.

Conclusion:

Topical applications of ZT demonstrated safety and established efficacy for initiating and maintaining anagen to treat male pattern baldness when applied for 6 months.

Research/References:

2017 Hair Therapy and Transplantation. Vickers ERAn Analysis of the Safety and Efficacy of Topical Zinc-Thymulin to treat Androgenetic Alopecia. 7:147

Meier N, Langan D, Hilbig H, Bodo E, Farjo NP, et al. (2012) Thymic peptides differentially modulate human hair follicle growth. J Invest Dermatol 132: 1516-1519.

Famenini S, Goh C (2014) Evidence for supplemental treatments in androgenetic alopecia. J Drugs Dermatol 13: 809-812